← Back to Search

Non-Contact Sleep Monitor for Alzheimer's Disease

N/A
Waitlist Available
Led By Kathleen Unroe, MD, MHA, MS
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Alzheimer's Disease (AD) or Alzheimer's Disease Related Dementias (ADRD)
Be older than 18 years old
Must not have
Currently on hospice
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if access to sleep quality data helps detect/treat sleep disturbances in people with Alzheimer's, leading to better sleep and less daytime physical inactivity.

Who is the study for?
This trial is for long-term care residents with Alzheimer's or related dementias who've been at the facility for at least 30 days. Participants can join themselves or through a legal rep if they can't make decisions. It's not open to those on hospice.
What is being tested?
The study tests a Non-Contact Sleep Quality Monitor System in monitoring sleep quality of individuals with Alzheimer's in long-term care. The impact of sharing real-time sleep data with caregivers on detecting and treating sleep disturbances is evaluated.
What are the potential side effects?
Since this trial involves non-contact monitoring, there are no direct side effects from the intervention itself. However, changes in treatment based on data may have their own effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Alzheimer's Disease or a related dementia.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently receiving hospice care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Documentation of sleep disorders or treatment
Secondary study objectives
Attitudes Toward Technology
Change in Epworth Sleepiness Scale Total Score Over Time
Change in QOL-AD Over Time
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Long-Term Care Facility Residents with Alzheimer's Disease or other Related DementiasExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,783 Previous Clinical Trials
28,184,123 Total Patients Enrolled
292 Trials studying Dementia
23,634,773 Patients Enrolled for Dementia
Indiana UniversityLead Sponsor
1,035 Previous Clinical Trials
1,218,879 Total Patients Enrolled
18 Trials studying Dementia
57,054 Patients Enrolled for Dementia
Innovative Design LabsUNKNOWN
1 Previous Clinical Trials
119 Total Patients Enrolled
~67 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top